Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion
NASDAQ:CYRX

CryoPort Q3 2026 Earnings Date & Estimates

CryoPort logo
$17.79 -0.19 (-1.06%)
Closing price 04:00 PM Eastern
Extended Trading
$17.80 +0.01 (+0.06%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CryoPort is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 5:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
5:00 PM ET

What Analysts Expect from CryoPort in Q3 2026

CryoPort is expected to post earnings of -$0.19 per share on revenue of $48.69 million. In the same quarter a year earlier CryoPort reported -$0.18 per share on revenue of $44.23 million. CryoPort last reported on August 6, 2026, posting -$0.20 per share and missing the -$0.1933 consensus estimate. CryoPort has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.19
Expected Revenue
$48.69 million
Prior-Year EPS
-$0.18
Prior-Year Revenue
$44.23 million
Expected Revenue Growth
+10.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.20 (Missed by -$0.0067)
Last Quarter Revenue
$48.97 million
EPS Beat Rate
3 of last 8 quarters

CryoPort Q3 2026 Earnings FAQ

CryoPort (NASDAQ:CYRX) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

CryoPort's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect CryoPort to post earnings of -$0.19 per share for Q3 2026.

The consensus revenue estimate for CryoPort is $48.69 million for Q3 2026.

CryoPort Earnings Headlines

Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.tc pixel
BTIG Remains a Buy on CryoPort (CYRX)
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
See More CryoPort Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CryoPort? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CryoPort and other key companies, straight to your email.

About CryoPort

CryoPort (NASDAQ:CYRX) (NASDAQ: CYRX) provides temperature-controlled supply chain solutions for the life sciences industry. The company supports the transportation, storage and management of biological materials, including cell and gene therapies, vaccines, biologics, reproductive materials and other temperature-sensitive products.

Its offerings include cryogenic and refrigerated shipping containers, biological material storage, transportation logistics, shipment monitoring and related supply chain management services. CryoPort’s technologies and services are designed to help preserve product integrity throughout the journey from research and manufacturing facilities to clinical trial sites, healthcare providers and patients.

Founded in 1999, CryoPort serves pharmaceutical, biotechnology, healthcare and reproductive medicine customers through operations and logistics capabilities spanning North America, Europe and other international markets. The company’s business includes specialized brands and service platforms focused on cryogenic equipment, global logistics and temperature-controlled storage.

View CryoPort Profile